更多...
收起
Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  端粒酶是一种核糖聚合酶通过加入端粒重复TTAGGG的端粒保持两端。酶由具有逆转录酶活性的蛋白质成分,由该基因编码的,并用作用于端粒重复的模板的RNA组分。端粒酶表达在细胞衰老的作用,因为它是在导致端粒渐进缩短产后体细胞通常抑制。在体细胞中端粒酶表达的失调可能参与肿瘤发生。在小鼠的研究表明,端粒酶还参与染色体修复,由于从头端粒重复序列的合成可在双链断裂发生。编码端粒酶逆转录酶已鉴定的不同同种型的可变剪接变体;一些变体的全长序列尚未确定。在这个位点的选择性剪接被认为是端粒酶活性的调节机制之一。 [由RefSeq的,2008年7月提供]
TERT基因(以及对应的蛋白质)的细胞分布位置:
TERT基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Idiopathic Pulmonary Fibrosis | 0.49298306 | 11 | 14 | BeFree_CLINVAR_CTD_human_GAD_GWASCAT_LHGDN_ORPHANET |
Glioma | 0.269237234 | 40 | 9 | BeFree_CTD_human_GAD_GWASCAT_LHGDN |
Dyskeratosis Congenita | 0.263870529 | 25 | 0 | BeFree_CTD_human_GAD_LHGDN_ORPHANET |
Aplastic Anemia | 0.247534359 | 11 | 12 | BeFree_CLINVAR_CTD_human_GAD_LHGDN |
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT | 0.241085767 | 4 | 7 | BeFree_CLINVAR_CTD_human |
HOYERAAL-HREIDARSSON SYNDROME | 0.240542884 | 2 | 0 | BeFree_CTD_human_ORPHANET |
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2 | 0.24 | 6 | 3 | CLINVAR_UNIPROT |
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1 | 0.24 | 5 | 16 | CLINVAR_UNIPROT |
Liver carcinoma | 0.156724105 | 62 | 1 | BeFree_CTD_human_LHGDN |
Lung Neoplasms | 0.156539878 | 18 | 2 | BeFree_CTD_human_GAD_LHGDN |
Malignant neoplasm of lung | 0.155418265 | 58 | 19 | BeFree_GAD_GWASCAT |
Mammary Neoplasms | 0.148600712 | 16 | 0 | BeFree_CTD_human_LHGDN |
Malignant neoplasm of breast | 0.13842571 | 37 | 18 | BeFree_GAD_GWASCAT |
Prostatic Neoplasms | 0.136531667 | 9 | 1 | BeFree_CTD_human_GAD_LHGDN |
Bladder Neoplasm | 0.134164635 | 8 | 0 | BeFree_CTD_human_LHGDN |
Thyroid Neoplasm | 0.133068936 | 13 | 0 | BeFree_CTD_human_LHGDN |
melanoma | 0.131596056 | 35 | 4 | BeFree_CTD_human_GAD |
Pancreatic Neoplasm | 0.131354408 | 8 | 2 | BeFree_CTD_human_GAD_LHGDN |
Non-Small Cell Lung Carcinoma | 0.127524428 | 19 | 2 | BeFree_CTD_human_GAD |
Adenocarcinoma of lung (disorder) | 0.126905599 | 11 | 4 | BeFree_GAD_GWASCAT |
Malignant neoplasm of prostate | 0.12643866 | 16 | 3 | BeFree_GAD_GWASCAT |
Neuroblastoma | 0.124624443 | 8 | 0 | BeFree_CTD_human_LHGDN |
Leukemia, Myelocytic, Acute | 0.124538567 | 8 | 2 | BeFree_CLINVAR_GAD |
Cri-du-Chat Syndrome | 0.123538676 | 3 | 0 | BeFree_CTD_human_LHGDN |
Malignant neoplasm of pancreas | 0.122985861 | 12 | 2 | BeFree_GWASCAT |
Uterine Cervical Neoplasm | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
ovarian neoplasm | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Basal cell carcinoma | 0.122367032 | 2 | 0 | CTD_human_GAD |
Coronary Artery Disease | 0.122367032 | 2 | 0 | CTD_human_GAD |
Myeloid Leukemia, Chronic | 0.121357209 | 6 | 0 | BeFree_CTD_human |
Epithelial ovarian cancer | 0.121357209 | 6 | 1 | BeFree_GWASCAT |
Lung Diseases, Interstitial | 0.120542884 | 3 | 1 | BeFree_GWASCAT |
Adrenocortical carcinoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Testicular malignant germ cell tumor | 0.120271442 | 1 | 1 | BeFree_GWASCAT |
Kidney Diseases | 0.12 | 1 | 0 | CTD_human |
Lymphoid leukemia | 0.12 | 1 | 0 | CTD_human |
Reperfusion Injury | 0.12 | 1 | 0 | CTD_human |
Disease Progression | 0.12 | 1 | 0 | CTD_human |
Aplastic anemia, idiopathic | 0.12 | 0 | 0 | ORPHANET |
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1 | 0.12 | 0 | 2 | CLINVAR |
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4 | 0.12 | 0 | 4 | CLINVAR |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9 | 0.12 | 0 | 0 | CLINVAR |
Squamous cell carcinoma | 0.025151793 | 23 | 2 | BeFree_GAD_LHGDN |
Glioblastoma | 0.018150387 | 22 | 4 | BeFree_GAD_LHGDN |
Carcinoma of lung | 0.014657861 | 54 | 18 | BeFree |
Colorectal Neoplasms | 0.013893193 | 6 | 0 | BeFree_LHGDN |
Carcinogenesis | 0.01302921 | 48 | 0 | BeFree |
Meningioma | 0.012168734 | 9 | 0 | BeFree_GAD_LHGDN |
Brain Neoplasms | 0.011539974 | 9 | 3 | BeFree_GAD_LHGDN |
Adenocarcinoma | 0.011530042 | 17 | 4 | BeFree_GAD_LHGDN |
Malignant neoplasm of urinary bladder | 0.011520111 | 27 | 4 | BeFree_GAD |
Stomach Neoplasms | 0.010897401 | 4 | 0 | LHGDN |
Pulmonary Fibrosis | 0.010172833 | 11 | 0 | BeFree_GAD_LHGDN |
Cholangiocarcinoma | 0.009258818 | 5 | 0 | BeFree_LHGDN |
Breast Carcinoma | 0.009229024 | 34 | 20 | BeFree |
leukemia | 0.007077352 | 8 | 0 | BeFree_LHGDN |
Carcinoma of bladder | 0.007057489 | 26 | 4 | BeFree |
Renal Cell Carcinoma | 0.006534468 | 6 | 0 | BeFree_LHGDN |
Neoplasm Metastasis | 0.006524536 | 14 | 1 | BeFree_LHGDN |
Malignant neoplasm of ovary | 0.00643866 | 15 | 0 | BeFree_GAD |
Endometriosis | 0.006263026 | 4 | 0 | BeFree_LHGDN |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.005991584 | 4 | 0 | BeFree_LHGDN |
Carcinoid Tumor | 0.005720142 | 2 | 0 | BeFree_LHGDN |
Fibroid Tumor | 0.005720142 | 3 | 0 | BeFree_LHGDN |
Multiple Myeloma | 0.005720142 | 3 | 1 | BeFree_LHGDN |
Anoxia | 0.0054487 | 2 | 0 | LHGDN |
Infection | 0.0054487 | 2 | 0 | LHGDN |
Colorectal Carcinoma | 0.004885954 | 18 | 1 | BeFree |
Stomach Carcinoma | 0.004885954 | 18 | 1 | BeFree |
Bone Marrow Diseases | 0.004734064 | 2 | 0 | GAD |
Malignant neoplasm of stomach | 0.004614512 | 17 | 1 | BeFree |
Ovarian Carcinoma | 0.004614512 | 17 | 0 | BeFree |
Sarcoma | 0.004353001 | 7 | 0 | BeFree_LHGDN |
Prostate carcinoma | 0.00434307 | 16 | 2 | BeFree |
Adenoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Cervix carcinoma | 0.004071628 | 15 | 0 | BeFree |
Thyroid carcinoma | 0.004071628 | 15 | 1 | BeFree |
Herpes Simplex Infections | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Pheochromocytoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Retinoblastoma | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Malignant tumor of cervix | 0.003800186 | 14 | 0 | BeFree |
Atherosclerosis | 0.003538676 | 4 | 1 | BeFree_LHGDN |
Chronic Lymphocytic Leukemia | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Tumor Progression | 0.003528744 | 13 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Pancreatic carcinoma | 0.003257302 | 12 | 1 | BeFree |
Malignant Glioma | 0.003257302 | 12 | 0 | BeFree |
Colorectal Cancer | 0.003257302 | 12 | 1 | BeFree |
Rheumatoid Arthritis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Gastritis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Lymphoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Nephroblastoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Papilloma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Rhabdomyosarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Hepatitis B | 0.002985861 | 11 | 0 | BeFree |
Anemia | 0.00272435 | 1 | 0 | LHGDN |
Ataxia Telangiectasia | 0.00272435 | 1 | 0 | LHGDN |
beta Thalassemia | 0.00272435 | 1 | 0 | LHGDN |
Chondrosarcoma | 0.00272435 | 1 | 0 | LHGDN |
Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Hyperplasia | 0.00272435 | 1 | 0 | LHGDN |
keratoacanthoma | 0.00272435 | 1 | 0 | LHGDN |
Laryngeal neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Acute Promyelocytic Leukemia | 0.00272435 | 1 | 0 | LHGDN |
Mixed Salivary Gland Tumor | 0.00272435 | 1 | 0 | LHGDN |
Myoma | 0.00272435 | 1 | 0 | LHGDN |
Nasal Polyps | 0.00272435 | 1 | 0 | LHGDN |
Tangier Disease | 0.00272435 | 1 | 0 | LHGDN |
Rhabdomyosarcoma, Embryonal | 0.00272435 | 1 | 0 | LHGDN |
Carcinoma, Endometrioid | 0.00272435 | 1 | 0 | LHGDN |
Carcinoma, Neuroendocrine | 0.00272435 | 1 | 0 | LHGDN |
Neuroendocrine Tumors | 0.00272435 | 1 | 0 | LHGDN |
Papillomavirus Infections | 0.00272435 | 1 | 0 | LHGDN |
Cleft palate with cleft lip | 0.002714419 | 10 | 1 | BeFree |
Cardiovascular Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
Coronary Arteriosclerosis | 0.002638474 | 2 | 1 | BeFree_GAD |
Skin Neoplasms | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of brain | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of thyroid | 0.002442977 | 9 | 1 | BeFree |
Cutaneous Melanoma | 0.002442977 | 9 | 0 | BeFree |
Asthma | 0.002367032 | 1 | 0 | GAD |
Cerebrovascular Disorders | 0.002367032 | 1 | 0 | GAD |
Eczema | 0.002367032 | 1 | 0 | GAD |
Hay fever | 0.002367032 | 1 | 0 | GAD |
Head and Neck Neoplasms | 0.002367032 | 1 | 0 | GAD |
Hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
Meningeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Germ Cell and Embryonal | 0.002367032 | 1 | 0 | GAD |
Testicular Neoplasms | 0.002367032 | 1 | 2 | GAD |
Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
Carcinoma, Transitional Cell | 0.002171535 | 8 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.002171535 | 8 | 1 | BeFree |
precancerous lesions | 0.002171535 | 8 | 0 | BeFree |
Liver neoplasms | 0.001900093 | 7 | 0 | BeFree |
Precancerous Conditions | 0.001900093 | 7 | 0 | BeFree |
Papillary thyroid carcinoma | 0.001900093 | 7 | 1 | BeFree |
Colon Carcinoma | 0.001628651 | 6 | 1 | BeFree |
Urothelial Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Liver Cirrhosis | 0.001357209 | 5 | 0 | BeFree |
Esophageal carcinoma | 0.001357209 | 5 | 0 | BeFree |
Central neuroblastoma | 0.001357209 | 5 | 0 | BeFree |
Non-Neoplastic Disorder | 0.001357209 | 5 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.001357209 | 5 | 0 | BeFree |
Nasopharyngeal carcinoma | 0.001357209 | 5 | 2 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.001357209 | 5 | 1 | BeFree |
Malignant tumor of colon | 0.001085767 | 4 | 1 | BeFree |
HIV Infections | 0.001085767 | 4 | 0 | BeFree |
Lung diseases | 0.001085767 | 4 | 0 | BeFree |
oligodendroglioma | 0.001085767 | 4 | 0 | BeFree |
Pancytopenia | 0.001085767 | 4 | 0 | BeFree |
Thyroid Nodule | 0.001085767 | 4 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.001085767 | 4 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.001085767 | 4 | 1 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Anaplastic Oligodendroglioma | 0.001085767 | 4 | 0 | BeFree |
Multiple malignancy | 0.001085767 | 4 | 2 | BeFree |
Malignant neoplasm of esophagus | 0.001085767 | 4 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.001085767 | 4 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.001085767 | 4 | 0 | BeFree |
Arteriosclerosis | 0.000814326 | 3 | 1 | BeFree |
Astrocytoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.000814326 | 3 | 0 | BeFree |
Esophageal Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000814326 | 3 | 0 | BeFree |
Liver diseases | 0.000814326 | 3 | 0 | BeFree |
Medulloblastoma | 0.000814326 | 3 | 0 | BeFree |
Small cell carcinoma of lung | 0.000814326 | 3 | 1 | BeFree |
Follicular thyroid carcinoma | 0.000814326 | 3 | 0 | BeFree |
Endometrial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.000814326 | 3 | 0 | BeFree |
Hepatocarcinogenesis | 0.000814326 | 3 | 0 | BeFree |
Cirrhosis | 0.000814326 | 3 | 0 | BeFree |
Uterine Corpus Cancer | 0.000814326 | 3 | 0 | BeFree |
Adrenal Gland Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Anaplasia | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of skin | 0.000542884 | 2 | 0 | BeFree |
Carcinoma, Papillary | 0.000542884 | 2 | 0 | BeFree |
Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
Hepatitis C | 0.000542884 | 2 | 0 | BeFree |
Pulmonary Hypertension | 0.000542884 | 2 | 0 | BeFree |
Inflammatory Bowel Diseases | 0.000542884 | 2 | 0 | BeFree |
Acute lymphocytic leukemia | 0.000542884 | 2 | 0 | BeFree |
Leukemia, Lymphocytic, Acute, L1 | 0.000542884 | 2 | 2 | BeFree |
Adult T-Cell Lymphoma/Leukemia | 0.000542884 | 2 | 0 | BeFree |
Pulmonary Emphysema | 0.000542884 | 2 | 0 | BeFree |
Soft Tissue Neoplasms | 0.000542884 | 2 | 0 | BeFree |
B-Cell Lymphomas | 0.000542884 | 2 | 0 | BeFree |
T-Cell Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Macrocytosis | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000542884 | 2 | 0 | BeFree |
Agenesis of corpus callosum | 0.000542884 | 2 | 0 | BeFree |
Follicular adenoma | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma, Clear Cell | 0.000542884 | 2 | 0 | BeFree |
Cervical Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
childhood brain tumor | 0.000542884 | 2 | 0 | BeFree |
Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.000542884 | 2 | 0 | BeFree |
Carcinoma, Small Cell | 0.000542884 | 2 | 1 | BeFree |
Acquired aplastic anemia | 0.000542884 | 2 | 1 | BeFree |
Solid tumour | 0.000542884 | 2 | 0 | BeFree |
Tumor necrosis | 0.000542884 | 2 | 0 | BeFree |
High-Grade Squamous Intraepithelial Lesions | 0.000542884 | 2 | 0 | BeFree |
Chronic liver disease | 0.000542884 | 2 | 0 | BeFree |
Human papilloma virus infection | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
Benign neoplasm of breast | 0.000542884 | 2 | 0 | BeFree |
Follicular neoplasm | 0.000542884 | 2 | 0 | BeFree |
Recurrent tumor | 0.000542884 | 2 | 1 | BeFree |
Leukemogenesis | 0.000542884 | 2 | 0 | BeFree |
Testicular Germ Cell Tumor | 0.000542884 | 2 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000542884 | 2 | 1 | BeFree |
Epithelioma | 0.000542884 | 2 | 0 | BeFree |
Tumor Immunity | 0.000542884 | 2 | 0 | BeFree |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Adenovirus Infections | 0.000271442 | 1 | 0 | BeFree |
Alzheimer's Disease | 0.000271442 | 1 | 0 | BeFree |
Ameloblastoma | 0.000271442 | 1 | 0 | BeFree |
Amputation Stumps | 0.000271442 | 1 | 0 | BeFree |
Cooley's anemia | 0.000271442 | 1 | 0 | BeFree |
Refractory anemias | 0.000271442 | 1 | 0 | BeFree |
Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
Melanoma, B16 | 0.000271442 | 1 | 0 | BeFree |
Basal Cell Nevus Syndrome | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of larynx | 0.000271442 | 1 | 0 | BeFree |
Rectal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Merkel cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Congenital chromosomal disease | 0.000271442 | 1 | 0 | BeFree |
Colonic Polyps | 0.000271442 | 1 | 7 | BeFree |
Common Variable Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Coronary heart disease | 0.000271442 | 1 | 1 | BeFree |
Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
Dermatomyositis | 0.000271442 | 1 | 6 | BeFree |
Diabetes Mellitus | 0.000271442 | 1 | 6 | BeFree |
Goiter | 0.000271442 | 1 | 0 | BeFree |
Hemangiosarcoma | 0.000271442 | 1 | 0 | BeFree |
Hepatitis | 0.000271442 | 1 | 0 | BeFree |
Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
Hepatitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
Hydatidiform Mole | 0.000271442 | 1 | 0 | BeFree |
Influenza | 0.000271442 | 1 | 0 | BeFree |
Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Kidney Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Leukoencephalopathy, Progressive Multifocal | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Non-Hodgkin | 0.000271442 | 1 | 6 | BeFree |
Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
Monosomy | 0.000271442 | 1 | 0 | BeFree |
Muscular Dystrophy | 0.000271442 | 1 | 0 | BeFree |
Nicotine Dependence | 0.000271442 | 1 | 5 | BeFree |
Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Extra-Adrenal Paraganglioma | 0.000271442 | 1 | 0 | BeFree |
Pleural effusion disorder | 0.000271442 | 1 | 0 | BeFree |
Adenomatous Polyposis Coli | 0.000271442 | 1 | 0 | BeFree |
Preleukemia | 0.000271442 | 1 | 0 | BeFree |
Retroviridae Infections | 0.000271442 | 1 | 0 | BeFree |
Sickle Cell Trait | 0.000271442 | 1 | 0 | BeFree |
Unipolar Depression | 0.000271442 | 1 | 0 | BeFree |
Uterine Fibroids | 0.000271442 | 1 | 0 | BeFree |
AIDS-Associated Nephropathy | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Large-Cell, Follicular | 0.000271442 | 1 | 6 | BeFree |
Peripheral T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Gestational Diabetes | 0.000271442 | 1 | 0 | BeFree |
Polymyositis | 0.000271442 | 1 | 6 | BeFree |
Chronic gastritis | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of nasopharynx | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.000271442 | 1 | 0 | BeFree |
Exudative retinopathy | 0.000271442 | 1 | 0 | BeFree |
Endometriosis of ovary | 0.000271442 | 1 | 0 | BeFree |
Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
Fibroadenoma | 0.000271442 | 1 | 0 | BeFree |
Hepatocellular Adenoma | 0.000271442 | 1 | 0 | BeFree |
Adult type dermatomyositis | 0.000271442 | 1 | 6 | BeFree |
Cancer of Nasopharynx | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Lewis Lung | 0.000271442 | 1 | 0 | BeFree |
Malignant Meningioma | 0.000271442 | 1 | 0 | BeFree |
Multiple tumors | 0.000271442 | 1 | 0 | BeFree |
Renal glomerular disease | 0.000271442 | 1 | 0 | BeFree |
Chronic viral hepatitis | 0.000271442 | 1 | 0 | BeFree |
Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma Of Esophagus | 0.000271442 | 1 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Endometrial Clear Cell Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Mixed Oligodendroglioma-Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.000271442 | 1 | 0 | BeFree |
Superficial ulcer | 0.000271442 | 1 | 0 | BeFree |
Clear cell sarcoma of kidney | 0.000271442 | 1 | 0 | BeFree |
Meningothelial meningioma | 0.000271442 | 1 | 0 | BeFree |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.000271442 | 1 | 0 | BeFree |
Malignant melanoma of conjunctiva | 0.000271442 | 1 | 0 | BeFree |
Splenic Marginal Zone B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of vulva | 0.000271442 | 1 | 0 | BeFree |
Hematopoietic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Nijmegen Breakage Syndrome | 0.000271442 | 1 | 0 | BeFree |
Non-alcoholic Fatty Liver Disease | 0.000271442 | 1 | 0 | BeFree |
Anaplastic Oligoastrocytoma | 0.000271442 | 1 | 0 | BeFree |
Osteosarcoma of bone | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of larynx | 0.000271442 | 1 | 0 | BeFree |
Hyperhomocysteinemia | 0.000271442 | 1 | 0 | BeFree |
Hashimoto Disease | 0.000271442 | 1 | 0 | BeFree |
Parathyroid Gland Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Skin carcinoma | 0.000271442 | 1 | 0 | BeFree |
Benign thyroid nodule | 0.000271442 | 1 | 1 | BeFree |
Adrenal Cancer | 0.000271442 | 1 | 0 | BeFree |
Idiopathic Inflammatory Myopathies | 0.000271442 | 1 | 0 | BeFree |
Genitourinary Cancer | 0.000271442 | 1 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.000271442 | 1 | 0 | BeFree |
Chromosome 10, monosomy 10q | 0.000271442 | 1 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Oestrogen deficiency | 0.000271442 | 1 | 0 | BeFree |
Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
Autoimmune thyroiditis | 0.000271442 | 1 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Ischemic stroke | 0.000271442 | 1 | 1 | BeFree |
Polyp of large intestine | 0.000271442 | 1 | 0 | BeFree |
Hurthle Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Major Depressive Disorder | 0.000271442 | 1 | 0 | BeFree |
Necrotic tumor | 0.000271442 | 1 | 0 | BeFree |
Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Nicolaides Baraitser syndrome | 0.000271442 | 1 | 0 | BeFree |
Atypical Adenomatous Lung Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of urinary bladder, superficial | 0.000271442 | 1 | 0 | BeFree |
grade I meningioma | 0.000271442 | 1 | 0 | BeFree |
Hereditary Melanoma | 0.000271442 | 1 | 0 | BeFree |
Primary Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Xenograft Model | 0.000271442 | 1 | 0 | BeFree |
Glioblastoma Multiforme | 0.000271442 | 1 | 0 | BeFree |
Basaloid carcinoma | 0.000271442 | 1 | 0 | BeFree |
ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1 | 0.000271442 | 1 | 0 | BeFree |
Prostate Cancer, Hereditary, 7 | 0.000271442 | 1 | 0 | BeFree |
Low grade glioma | 0.000271442 | 1 | 0 | BeFree |
Promyelocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Bone Marrow failure syndromes | 0.000271442 | 1 | 0 | BeFree |
Peri-Implantitis | 0.000271442 | 1 | 0 | BeFree |
Myeloid neoplasm | 0.000271442 | 1 | 0 | BeFree |
Inherited bone marrow failure syndrome | 0.000271442 | 1 | 0 | BeFree |
Primary acquired melanosis | 0.000271442 | 1 | 0 | BeFree |
Ischemic Cerebrovascular Accident | 0.000271442 | 1 | 1 | BeFree |
Gastric Schwannoma | 0.000271442 | 1 | 0 | BeFree |
Well Differentiated Hepatocellular Carcinoma | 0.000271442 | 1 | 0 | BeFree |
MYELODYSPLASTIC SYNDROME | 0.000271442 | 1 | 0 | BeFree |
Homocysteinemia | 0.000271442 | 1 | 0 | BeFree |
Dyskeratosis Congenita, Autosomal Recessive | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。